About Recro

Recro (NASDAQ: REPH) is a revenue generating Contract Development and Manufacturing Organization (CDMO) with capabilities from early feasibility and product development solutions through to commercial manufacturing.

Recro owns and operates a 97,000 SF DEA Licensed facility in Gainesville, GA that manufactures commercial cGMP products for companies in the U.S. and abroad. In addition, Recro leases a 24,000 SF also located in Gainesville, GA that provides product development services for oral dose forms with complexities as well as for high potency products of certain categories.

Recro has provided updated financial guidance for 2019 in its recent 3rd Quarter 10Q filing, press release and earnings call.